Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial.

Tauber E, Kollaritsch H, Korinek M, Rendi-Wagner P, Jilma B, Firbas C, Schranz S, Jong E, Klingler A, Dewasthaly S, Klade CS.

Lancet. 2007 Dec 1;370(9602):1847-53.

PMID:
18061060
3.

Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.

Wang SY, Cheng XH, Li JX, Li XY, Zhu FC, Liu P.

Hum Vaccin Immunother. 2015;11(6):1418-25. doi: 10.1080/21645515.2015.1011996. Review.

4.

A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.

Kim DS, Houillon G, Jang GC, Cha SH, Choi SH, Lee J, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Kim HS, Bang J, Naimi Z, Bosch-Castells V, Boaz M, Bouckenooghe A.

Hum Vaccin Immunother. 2014;10(9):2656-63. doi: 10.4161/hv.29743. Epub 2014 Nov 6.

5.

Phase III clinical trials comparing the immunogenicity and safety of the vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain.

Miyazaki C, Okada K, Ozaki T, Hirose M, Iribe K, Yokote H, Ishikawa Y, Togashi T, Ueda K.

Clin Vaccine Immunol. 2014 Feb;21(2):188-95. doi: 10.1128/CVI.00377-13. Epub 2013 Dec 11.

6.

Japanese encephalitis vaccine (inactivated, adsorbed) [IXIARO].

Duggan ST, Plosker GL.

Drugs. 2009;69(1):115-22. doi: 10.2165/00003495-200969010-00008.

PMID:
19192940
7.

Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK(®)V) in children.

Okada K, Iwasa T, Namazue J, Akechi M, Ueda S; JE Vaccine Clinical Study Group..

Vaccine. 2012 Sep 7;30(41):5967-72. doi: 10.1016/j.vaccine.2012.07.034. Epub 2012 Jul 25.

PMID:
22841478
8.

One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.

Cramer JP, Jelinek T, Paulke-Korinek M, Reisinger EC, Dieckmann S, Alberer M, Bühler S, Bosse D, Meyer S, Fragapane E, Costantini M, Pellegrini M, Lattanzi M, Dovali C.

J Travel Med. 2016 Mar 19;23(3). pii: taw011. doi: 10.1093/jtm/taw011. Print 2016 Mar.

PMID:
26994987
9.

The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.

Erra EO, Kantele A.

Expert Rev Vaccines. 2015;14(9):1167-79. doi: 10.1586/14760584.2015.1061939. Epub 2015 Jul 10. Review.

PMID:
26162529
10.

Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.

Rabe IB, Miller ER, Fischer M, Hills SL.

Vaccine. 2015 Jan 29;33(5):708-12. doi: 10.1016/j.vaccine.2014.11.046. Epub 2014 Dec 9.

PMID:
25498208
11.

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.

Ramsauer K, Schwameis M, Firbas C, Müllner M, Putnak RJ, Thomas SJ, Desprès P, Tauber E, Jilma B, Tangy F.

Lancet Infect Dis. 2015 May;15(5):519-27. doi: 10.1016/S1473-3099(15)70043-5. Epub 2015 Mar 2.

PMID:
25739878
12.

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®).

Schuller E, Klingler A, Dubischar-Kastner K, Dewasthaly S, Müller Z.

Vaccine. 2011 Nov 3;29(47):8669-76. doi: 10.1016/j.vaccine.2011.08.117. Epub 2011 Sep 10.

PMID:
21907747
13.

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials.

Torresi J, McCarthy K, Feroldi E, Méric C.

Vaccine. 2010 Nov 23;28(50):7993-8000. doi: 10.1016/j.vaccine.2010.09.035. Epub 2010 Oct 8.

PMID:
20934459
14.

Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).

Kikukawa A, Gomi Y, Akechi M, Onishi T, Manabe S, Namazue J, Fuke I, Ishikawa T, Okuno Y, Ueda S.

Vaccine. 2012 Mar 16;30(13):2329-35. doi: 10.1016/j.vaccine.2012.01.054. Epub 2012 Jan 31.

PMID:
22306856
15.

Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.

Woolpert T, Staples JE, Faix DJ, Nett RJ, Kosoy OI, Biggerstaff BJ, Johnson BW, Sracic M, Fischer M.

Vaccine. 2012 Apr 26;30(20):3090-6. doi: 10.1016/j.vaccine.2012.02.063. Epub 2012 Mar 6.

PMID:
22406277
16.

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.

Lobigs M, Pavy M, Hall RA, Lobigs P, Cooper P, Komiya T, Toriniwa H, Petrovsky N.

J Gen Virol. 2010 Jun;91(Pt 6):1407-17. doi: 10.1099/vir.0.019190-0. Epub 2010 Feb 3.

17.

Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine.

Kuzuhara S, Nakamura H, Hayashida K, Obata J, Abe M, Sonoda K, Nishiyama K, Sugawara K, Takeda K, Honda T, Matsui H, Shigaki T, Kino Y, Mizokami H, Tanaka M, Mizuno K, Ueda K.

Vaccine. 2003 Nov 7;21(31):4519-26.

PMID:
14575762
18.

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P.

J Infect Dis. 2003 Oct 15;188(8):1213-30. Epub 2003 Oct 3.

PMID:
14551893
19.

[Study on safety and effect of purified inactivited Japanese encephalitis vaccine (primary hamster kidney cell, PHK)].

Li W, Jia LL, Zou Y.

Zhongguo Yi Miao He Mian Yi. 2009 Aug;15(4):333-6. Chinese.

PMID:
20077733
20.

IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.

Appaiahgari MB, Vrati S.

Expert Rev Vaccines. 2010 Dec;9(12):1371-84. doi: 10.1586/erv.10.139. Review.

PMID:
21105774

Supplemental Content

Support Center